Position Overview:

The Head of Investor Relations will be a strategic, thoughtful, entrepreneurial, and motivated leader who will build, own, and lead a world-class Investor Relations function. This individual will develop and execute a proactive investor relations strategy and narrative to capture and expand top-tier investor and analyst engagement, grow market cap, increase shareholder value, and ensure Prothena is best positioned in the eyes of a demanding and risk-averse investment community, as well as other external stakeholder audiences.

As a welcomed partner and advisor to Prothena's leadership team, board, and overall business, the Head of Investor Relations will effectively convey Prothena's transformative vision, business strategy, goals, achievements, progress, and opportunities, providing timely and consistent messaging regarding operational and financial objectives, and realistic performance expectations. Serving as a key externally facing contact for the investment community, he or she will craft and present a compelling story that reinforces the company's shared purpose and core values, showcasing Prothena's commanding expertise in protein dysregulation and diverse, robust pipeline of novel investigational therapies for rare peripheral amyloid and neurodegenerative diseases.

Responsibilities:

• Developing a deep and thorough understanding of the company's science, R&D pipeline, strategy, and the broader neurodegeneration drug development and commercial market
• Leading the development and execution of a targeted investor relations strategy and best-in-class practices to maximize the company's long-term value creation. This will include supporting and orchestrating financial results/quarterly earnings processes, messaging, press releases, analyst/investor meetings, and events, including annual R&D Day, non-deal roadshows, anticipated Q&A, regulatory filings, and other related materials
• Building strong partnerships across functions, such as finance, legal, commercial, medical affairs, research, and clinical development, to enable accurate and optimal creation, evolution, and delivery of key messages, and ensure that investor communications are aligned with communications across all internal and external audiences
• In close partnership with the executive team, playing a key leadership role in the development of short-, mid-, and long-term capital-raising strategies that are aligned with overall corporate strategy and goals and ensure continued progress of Prothena's programs. These will include all available funding opportunities, such as equity, royalty, convertible debt, and other financial vehicles
• Conducting benchmarking and analysis of peers and industry trends to inform a best-in-class IR program and support continued business growth

Requirements:

Education and Experience:

• BS or BA (required), advanced degree highly preferred
• Successful leadership of best-in-class investor relations at a publicly traded pharma/biopharma/biotech company (ideally including global, fully integrated, commercial-stage biopharma/pharma and small public company experience)

Competencies and Attributes:

• Demonstrated leadership to drive results that are needed to achieve company objectives in accord with Prothena's culture and values – courageous, imaginative, selfless and joyful
• Proven track record of developing and implementing a robust investor relations strategy— building and elevating investor and analyst coverage to help ensure continued corporate growth
• Demonstrated record of collaborative "we/team" leadership success during periods of corporate growth or change
• Strategic and tactical leadership to drive results and achieve company objectives aligned with Prothena's values and evolving culture
• Highly articulate, creative, and persuasive communicator with outstanding externally facing presentation skills and gravitas; a thought partner to the executive team, board, and business, continuously striving to improve the investor story
• Well-equipped to understand the science, business strategy, industry, and competitor developments to sufficiently identify issues and effectively communicate with all internal and external stakeholders
• High-level financial and business acumen; understanding valuation models, capital structure, equity markets, and the impact of various components on a company's stock price/valuation, accounting and financial statements, profitability measures, and operating metrics
• Excellent business writing skills—capable of independently writing clear, concise, and error-free complex documents, such as press releases, external company presentations, annual/quarterly reports, SEC filings, conference call scripts, and Q&As
• Innovative, nimble, pragmatic, and resourceful to craft solutions for unique, complex problems that have a broad impact on the business
• Thrives in a results-driven, accountable environment and excited to "build" a high-performing function
• Works with speed, intention, focus, and the ability to act decisively in ambiguous situations, bringing a consultative approach to overcome challenges
• Ability to operate with candid transparency, strong "read the room" EQ, professionalism, and the highest degree of integrity
• A team player who listens effectively and invites response and discussion

Compensation Overview:

The anticipated annual salary range for this role is $260,000 to $340,000. This is the lowest to highest salary we in good faith believe we would pay for this role at the time of this posting. We may ultimately pay more or less than the posted range, and the range may be modified in the future. The final salary offered to a successful candidate will be dependent on several factors that may include – but are not limited to – the final job level offered, the type and length of experience within the job and industry, relevant education, qualifications, skills, certifications, performance, and business or organizational needs.

The hired applicant will be eligible to receive an annual bonus and an equity grant in the form of stock options.